Skip to search formSkip to main contentSkip to account menu

Cetuximab-IRDye 800CW

Known as: Cetuximab-IRDye 800, Cetuximab-IRDye800, Cetuximab-IRDye800CW 
An immunoconjugate comprised of the recombinant chimeric monoclonal antibody cetuximab conjugated to the N-hydroxysuccinamide (NHS) ester form of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Sex differences in endothelial function in the porcine coronary artery
The prevalence of cardiovascular disease is lower in premenopausal women compared to age-matched males and postmenopausal females… 
2015
2015
Macromolecular Dexamethasone Prodrug Prevents And Resolves Lupus Nephritis With Reduced Systemic Toxicities
SUMMARY Macromolecular dexamethasone prodrug (PDex) was found to be able to prevent and resolve lupus nephritis much more… 
2013
2013
Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast
Ductal carcinoma in situ (DCIS) of the breast is difficult to remove completely during surgery as it is not palpable and can… 
2013
2013
64Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated IRDye 800CW (a near-infrared fluorescence dye) coupled to mAb7, an anti-epithelial cell adhesion molecule…
2012
2012
Near-infrared Dye®800CW–conjugated disulfide-based cyclic RGD peptide c(CRGDKGPDC) and its DOTA analog
2011
2011
Comparison between Loop-mediated isothermal amplification (LAMP) assay and conventional PCR for rapid detection of toxigenic Vibrio cholerae
Introduction: Cetuximab (IMC-C225) is a monoclonal antibody directed against the epidermal growth factor receptor (EGFR) and thus… 
2009
2009
The Next Step in Near Infrared Fluorescence: IRDye® QC-1 Dark Quencher
Cells, tissues, plastics, blotting membranes, and chemical compound libraries all exhibit autofluorescence that can interfere… 
2009
2009
IRDye 700DX-Labeled annexin V
2008
2008
Biweekly cetuximab (C), oxaliplatin (Ox), and capecitabine (Cape) in first line therapy of metastatic colorectal cancer (mCRC): Preliminary results on toxicity and K-ras status
15060 Background: In a novel q2w schedule, this trial combined Ox and flat dosing of cape with C in first line therapy of mCRC. C… 
2005
2005
肺癌細胞株における cetuximab (IMC-C225) を介した抗体依存的細胞障害活性の検討(14 新たな治療の試み, 第46回 日本肺癌学会総会)